Clinical Trial Symposium: DIRECT - candesartan and the primary and secondary prevention of retinopathy and nephropathy

Background and design of the DIRECT Programme A.K. Sjølie

Title: Author: Background and design of the DIRECT Programme A.K. Sjølie

Effect of candesartan on incidence and progression of retinopathy in type 1... N. Chaturvedi

Title: Author: Effect of candesartan on incidence and progression of retinopathy in type 1 diabetic patients (DIRECT-Prevent 1 and DIRECT-Protect 1) N. Chaturvedi

Effect of candesartan on progression of retinopathy in type 2 diabetic patients A.K. Sjølie

Title: Author: Effect of candesartan on progression of retinopathy in type 2 diabetic patients (DIRECT-Protect 2) A.K. Sjølie

Critical evaluation (independent commentator) K.F. Hanssen

Title: Author: Critical evaluation (independent commentator) K.F. Hanssen